Glued IOL Live Surgery on July 5,2014 IIRSI, Chennai

Glued IOL Live Surgery on July 5,2014 IIRSI, Chennai (532)

IIRSI 2014 Conference held at Chennai from July 5,6 2014 : A Report

IIRSI IIRSI 2014 Conference held at Chennai from July 5,6 2014 : A Report (Dr Sarbjit Singh)

Please follow the links for the photographs of the two day conference

Saturday, July 5, 2015
Sunday, July 6, 2014

The Indian Intra-ocular Implant & Refractive Surgery Convention was held from July 5, 2014 to July 6, 2014 under the aegis of Intra-Ocular Implant & Refractive Society, India (IIRSI). This was the annual conference of IIRSI and what was feast of ophthalmic knowledge and interaction it was. There was a record number of 1600 registered delegates from India and overseas.

Dr. Kumar J. Doctor, the outgoing president gave way to Dr Noshir M. Shroff, the incoming president of IIRSI. (more…) (1017)

REVISED – SCIENTIFIC PROGRAM OF ANNUAL CONF. OF IIRSI – 5-6 JULY 2014, CHENNAI, INDIA

AsianOphthalmology Alliance logo REVISED – SCIENTIFIC PROGRAM OF ANNUAL CONF. OF IIRSI – 5-6 JULY 2014, CHENNAI, INDIA

IIRSI – REVISED (Click to view and download)

(698)

Pre-Descemet’s endothelial keratoplasty (PDEK)

AsianOphthalmology Alliance logo Pre-Descemet’s endothelial keratoplasty (PDEK)

Incorporation of Dua’s layer for creation of Type-1 bubble in Pre-Descemet’s endothelial keratoplasty. Check out this new publication in BJO- with Dr. HarminderSingh Dua

Amar Agarwal1, Harminder S Dua2, Priya Narang3, Dhivya A Kumar1, Ashvin Agarwal1, Soosan Jacob1, Athiya Agarwal1, Ankur Gupta2

To read about it Click Here

British Journal of Ophthalmology (684)

Office-based vitrectomy: proceed with caution

AsianOphthalmology Alliance logo Office-based vitrectomy: proceed with caution

In a pro/con session during AAO 2013 Retina meeting, Thomas M. Aaberg Jr, MD, and Steven T. Charles, MD, argued the merits of office-based vitrectomy.

Rationale for. Primary reasons for making the switch include cost, convenience, and control, Dr. Aaberg said. Proper patient and case selection is essential, he cautioned. With that as the starting point, “In every case we’ve performed, we’ve been able to achieve all of our surgical goals,” he added.

He noted that safety (more…) (2091)

Ex-Press shunt, trabeculectomy yield similar outcomes

AsianOphthalmology Alliance logo Ex-Press shunt, trabeculectomy yield similar outcomes

This multicenter, prospective, randomized study compared outcomes with trabeculectomy (61 eyes) and the Ex-Press glaucoma filtration implant (59 eyes) placed under a partial-thickness scleral flap. At two years follow-up, outcomes were similar in terms of mean IOPs, medication use, and surgical success.

Although the Ex-Press group returned to baseline vision quicker, visual recovery was similar. The Ex-Press group experienced less IOP variation during the early postop period, and fewer postop complications (P = 0.013).

American Journal of Ophthalmology, February 2014 (3711)

Dr Quresh Maskati takes over as President of AIOS

Dr Quresh Maskati Dr Quresh Maskati takes over as President of AIOS

A big & hearty congratulations to our own Dr Quresh on his installation as President of the All India Ophthalmological Society (AIOS) during the 2014 Annual Conference of the society held in the city of Agra in India.

The society is safe and in competent hands and we have no doubts that it shall reach new heights during the tenure of Dr Quresh.

Best wishes Dr Quresh Maskati from all the members of AsianOphthalmology Alliance.

Regards

Dr Sarbjit Singh

http://asianophthalmology.org

- Installation of Dr Quresh Maskati as AIOS President (2min 42sec Video) Click to View

- Presidential Address (16min 04sec Video) Click to view

- Presidential Address presentation (pdf) (1.3MB) Click to view

(617)

Risk factors for acute postoperative intraocular pressure elevation after phacoemulsification in glaucoma patients

AsianOphthalmology Alliance logo Risk factors for acute postoperative intraocular pressure elevation after phacoemulsification in glaucoma patients

Author(s): Slabaugh M, Bojikian K, Moore D, Chen P
Treatments discussed: acetazolamide

PURPOSE To evaluate the risk factors for and frequency of an acute intraocular pressure (IOP) elevation (spike) after phacoemulsification in patients with glaucoma.

(more…) (3290)

FDA accepts Regeneron’s Eylea sBLA for standard review

AsianOphthalmology Alliance logo FDA accepts Regeneron’s Eylea sBLA for standard review

The supplemental Biologics License Application (sBLA) on Eylea intravitreal injection (aflibercept, Regeneron, Tarrytown, N.Y.) for the treatment of diabetic macular edema (DME) has been accepted by the Food and Drug Administration, with a targeted Prescription Drug User Fee Act date of August 18, 2014.

The submission was based on positive data from Regeneron’s VIVID and VISTA studies. Eylea is currently approved in the U.S. for neovascular age-related macular degeneration and for macular edema following central retinal vein occlusion.

EyeWorld Weekly Update (1755)

Complications of Glued IOL : Dr Priya Narang

Healio_OSN: BLOG: Complications of glued IOL, by Priya Narang, MS. Read it here: http://ow.ly/rRsOX (1047)

« Previous PageNext Page »